menu search

3 biotech stocks that could make you richer in october and beyond

Three Motley Fool contributors think these biotech stocks should be big winners....

October 7, 2021, 6:02 am

Cathie wood sells $49.4m in tesla and buys $87.5m in ginkgo bioworks on dip as stock becomes target of short sellers

Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock w...

October 6, 2021, 10:38 pm

Cathie wood sells $49.4m in tesla and buys $87.5m in ginkgo bioworks on dip as stock becomes target of short sellers

Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock w...

October 6, 2021, 10:38 pm

Cathie wood sells $49.4m in tesla and buys $87.5m in ginkgo bioworks on dip as stock becomes target of short sellers

Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock w...

October 6, 2021, 10:38 pm

Puma biotechnology reports inducement awards under nasdaq listing rule 5635(c)(4)

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported inducement awards granted in Sept. 2021 to six non-executive employees, as required under Na...

October 6, 2021, 5:01 pm

Puma biotechnology reports inducement awards under nasdaq listing rule 5635(c)(4)

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported inducement awards granted in Sept. 2021 to six non-executive employees, as required under Na...

October 6, 2021, 5:01 pm

Puma biotechnology reports inducement awards under nasdaq listing rule 5635(c)(4)

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported inducement awards granted in Sept. 2021 to six non-executive employees, as required under Na...

October 6, 2021, 5:01 pm

Why investing in vxrt stock is a coin flip

Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine. The post Why Investing in VXRT Stock...

October 6, 2021, 12:03 pm

Why investing in vxrt stock is a coin flip

Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine. The post Why Investing in VXRT Stock...

October 6, 2021, 12:03 pm

Why investing in vxrt stock is a coin flip

Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine. The post Why Investing in VXRT Stock...

October 6, 2021, 12:03 pm

Is this the turning point for inovio?

The biotech's streak of bad luck may be about to end, but risks remain....

October 6, 2021, 11:15 am

Is this the turning point for inovio?

The biotech's streak of bad luck may be about to end, but risks remain....

October 6, 2021, 11:15 am

Is this the turning point for inovio?

The biotech's streak of bad luck may be about to end, but risks remain....

October 6, 2021, 11:15 am

Aikido pharma trading 30% below cash value despite positive indications

Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. (NASDAQ: AIKI) recently released its 1st-quarter report, which r...

October 6, 2021, 9:27 am

Aikido pharma trading 30% below cash value despite positive indications

Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. (NASDAQ: AIKI) recently released its 1st-quarter report, which r...

October 6, 2021, 9:27 am

Aikido pharma trading 30% below cash value despite positive indications

Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. (NASDAQ: AIKI) recently released its 1st-quarter report, which r...

October 6, 2021, 9:27 am

Entheon biomedical acquires lobo genetics, inc. in bid to strengthen screening and treatment evaluation tech for psychedelics

Image Provided by Wiki Commons Entheon Biomedical Corp. (OTCQB: ENTBF), the biotech research and develo...

October 6, 2021, 9:22 am

Entheon biomedical acquires lobo genetics, inc. in bid to strengthen screening and treatment evaluation tech for psychedelics

Image Provided by Wiki Commons Entheon Biomedical Corp. (OTCQB: ENTBF), the biotech research and develo...

October 6, 2021, 9:22 am

Entheon biomedical acquires lobo genetics, inc. in bid to strengthen screening and treatment evaluation tech for psychedelics

Image Provided by Wiki Commons Entheon Biomedical Corp. (OTCQB: ENTBF), the biotech research and develo...

October 6, 2021, 9:22 am

Voyager therapeutics stock, a beaten-down biotech, soars on pfizer license deal

Shares of a small biotech called Voyager Therapeutics surged after the company said Pfizer had licensed...

October 6, 2021, 8:58 am


Search within

Pages Search Results: